Provided by Tiger Trade Technology Pte. Ltd.

Taysha Gene Therapies, Inc.

5.16
-0.1800-3.37%
Pre-market: 5.260.1000+1.94%09:12 EDT
Volume:2.40M
Turnover:12.32M
Market Cap:1.68B
PE:-12.51
High:5.24
Open:5.24
Low:5.01
Close:5.34
52wk High:7.30
52wk Low:2.71
Shares:325.83M
Float Shares:233.00M
Volume Ratio:1.20
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4126
EPS(LYR):-0.3409
ROE:-47.05%
ROA:-23.82%
PB:4.34
PE(LYR):-15.14

Loading ...

Why Taysha Gene Therapies (TSHA) Is Up 12.4% After Institutions Tighten Their Grip On Shares

Simply Wall St.
·
Jun 20

Taysha’s TSHA-102 Rett Data Links Clinical Promise To Future Revenue

Simply Wall St.
·
Jun 13

Taysha Gene Therapies grants new hires 714,700 RSUs, 468,600 options at $5.97 under inducement plan

Reuters
·
Jun 05

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Taysha Gene Therapies Shareholders Back Governance and Leadership

TIPRANKS
·
Jun 03

Taysha Gene Therapies shareholders elected two directors at annual meeting

Reuters
·
Jun 03

ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors

TIPRANKS
·
May 23

A Look At Taysha Gene Therapies (TSHA) Valuation After FDA Alignment On TSHA-102 BLA Pathway

Simply Wall St.
·
May 11

Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA

TIPRANKS
·
May 11

Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway

TIPRANKS
·
May 07

Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)

TIPRANKS
·
May 07

Chardan Capital Remains a Buy on Taysha Gene Therapies (TSHA)

TIPRANKS
·
May 07

Taysha Gene Therapies Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 06

Taysha Gene Therapies Q1 net loss widens on higher R&D costs

Reuters
·
May 06

Taysha Gene Therapies Q1 EPS $(0.12) Misses $(0.10) Estimate

Benzinga Earnings
·
May 06

BRIEF-Taysha Gene Therapies Q1 Net Income USD -42.41 Million

Reuters
·
May 06

Taysha Gene Therapies Q1 Operating Income USD -43.486 Million

THOMSON REUTERS
·
May 06

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 06

Taysha Gene Therapies grants 188,000 RSUs to five new employees under inducement plan

Reuters
·
May 02

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 02